Tizaterkib
Tizaterkib (AZD0364) is a potent and selective ERK2 inhibitor extracted from patent WO2017080979A1, compound example 18, has an IC50 of 0.6 nM.
Product Specifications
CAS Number
2097416-76-5
Product Name Alternative
AZD0364
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ERK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AZD-0364.html
Purity
99.31
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C1C2=NC(C3=NC(NC4=CC=NN4C)=NC=C3C)=CN2C[C@H](COC)N1CC5=CC=C(F)C(F)=C5
Molecular Formula
C24H24F2N8O2
Molecular Weight
494.50
Precautions
H302, H315, H319, H335
References & Citations
[1]WARD, Richard, Andrew, et al. DIHYDROIMIDAZOPYRAZINONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER. WO2017080979A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ERK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CCG-1011-20 1 mL
Gal b(1,3)GalNac b-O-BSA Colloidal Gold Conjugate, 1mL 20nm
Sign In for Pricing
View Details 